HRMY - Harmony Biosciences Holdings Inc
28.79
0.050 0.174%
Share volume: 544,083
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$28.74
0.05
0.00%
Summary score
66%
Profitability
87%
Dept financing
27%
Liquidity
75%
Performance
53%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
10.57%
Return on assets
5.4%
Return on sales
28.27%
Return on invested capital
22.72%
Total debt ratio
39.12%
Debt ratio change over timeo
1.21%
Current Ratio
3.93%
Quick Ratio
3.89%
Cash Position Ratio
3.08%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
4.58%
Return on sales
24.54%
Return on invested capital
0%
Total debt ratio
31.39%
Debt ratio change over timeo
0%
Current Ratio
3.67%
Quick Ratio
3.64%
Cash Position Ratio
2.89%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
3.02%
Return on sales
15.82%
Return on invested capital
0%
Total debt ratio
31.57%
Debt ratio change over time
0%
Current Ratio
3.6%
Quick Ratio
3.58%
Cash Position Ratio
2.98%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-49.63%
Return on assets
-69.48%
Return on sales
60.38%
Return on invested capital
9.69%
Total debt ratio
121.07%
Debt ratio change over time
1.21%
Current Ratio
20.56%
Quick Ratio
20.3%
Cash Position Ratio
16.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HRMY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 10.57% | 12.23% | 10.41% | 0% |
| Return on assets | 5.4% | 4.74% | 3.19% | 1.73% |
| Return on sales | 28.27% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 22.72% | 8.04% | 10.95% | 0% |
| Profitability | 94% | 81% | 69% | 27% |
| Total debt ratio | 39.12% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 1.21% | -20.57% | -85.61% | 17.33% |
| Dept financing | 12% | 21% | 16% | 50% |
| Current Ratio | 3.67% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.64% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 2.89% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 15% | 17% | 12% |
| Short-term ratios | HRMY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 4.58% | 6.06% | 4.18% | 1.7% |
| Return on sales | 24.54% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 84% | 50% | 34% | 23% |
| Total debt ratio | 31.39% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 33% | 20% | 15% | 25% |
| Current Ratio | 3.67% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.64% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 2.89% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 19% | 17% | 10% |